“…Despite some problems with relatively low tumor uptake in some cancer applications, there is today a number of promising alternatives that have been tested or are under the development [57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90]. Below follows a presentation of important and interesting NP alternatives suitable for PCa and BC, some of which already have been tested for these type of diseases while some are still to be explored more thoroughly.…”